Lv63
1980 积分 2024-09-06 加入
US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant, PIK3CA -Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, Locally Advanced or Metastatic Breast Cancer
5小时前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1天前
已完结
CAR T cell–mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis
1天前
已完结
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
6天前
已完结
Safety and Efficacy of Autologous RNA Chimeric Antigen Receptor T-cell (rCAR-T) Therapy in Myasthenia Gravis: a prospective, multicenter, open-label, non-randomised phase 1b/2a study
1个月前
已完结
Chimeric antigen receptors of HBV envelope proteins inhibit hepatitis B surface antigen secretion
2个月前
已完结
A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice
2个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
3个月前
已完结
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
3个月前
已完结
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases
3个月前
已完结
皖公网安备34019202002308
